Vaccine
RBD
VIRUS
The vaccine was manufactured by Laboratorio Pablo Cassará S.R.L, according to good manufacturing practice guidelines. The recombinant protein was produced in a CHO-S-cell line and consisted of a single-chain dimer of the receptor binding domain (RBD), comprising amino acids 319 R to 537 K of the Spike protein from Gamma SARS-CoV-2 virus variant. ARVAC CG consisted in a liquid formulation containing 25 μg or 50 μg per 0.5 mL in a vial, with aluminum hydroxide as the adjuvant